Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginkgo biloba + prednisone acetate for tinnitus after cochlear implantation
ChiCTR2500108098Phase 4Recruiting
- Sponsor
- Shandong Second Provincial General Hospital
- Start
- Aug 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ginkgo biloba extract and prednisone acetate in tinnitus (3 arms), sponsored by Shandong Second Provincial General Hospital. Primary endpoints: Tinnitus Functional Index (TFI) and Tinnitus Handicap Inventory (THI). Started Aug 2025; status: recruiting.
02
Drugs
ginkgo biloba extractprednisone acetate
03
Conditions
tinnitus
Beyond the preview
Go deeper on ChiCTR2500108098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108098.